The effect of active rumination training on negative emotions during the treatment of non convulsive electroconvulsive therapy in patients with depression

DOI: 10.12201/bmr.202509.00013

•  

  Abstract: Objective: To explore the effect of Positive Ruminative Thinking Training (PRT) on negative emotions during seizure free electroconvulsive therapy (MECT) in patients with depression. Method: 80 patients with depression who received MECT in our hospital from February 2024 to February 2025 were selected and randomly divided into a control group and an observation group, with 40 patients in each group, using a random number table method. The control group received routine intervention, while the observation group received PRT on the basis of the control group. Both groups were intervened until the end of MECT, and all patients with depression received 8-12 sessions of MECT treatment. Compare the negative emotions, self-efficacy, and positive and negative rumination scale (PANRS) between the two groups before and after intervention, and compare the adverse reactions after the intervention. Result: After intervention, the scores of anxiety, depression scale, and negative factor rumination thinking in the observation group were lower than those in the control group. The scores of general self-efficacy scale and positive factor rumination thinking were higher than those in the control group, and the differences were statistically significant (all P<0.05); The total incidence of adverse reactions in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05). Conclusion: PRT can reduce negative emotions and negative rumination thinking in patients with depression during MECT, improve positive rumination thinking and self-efficacy, and reduce the incidence of adverse reactions caused by MECT.

  Key words: Positive rumination thinking; depression; Non convulsive electroconvulsive therapy; Negative emotions

  Submit time: 3 September 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Negative Emotion and Ruminating Meditation as a Chain Mediator between the Quality of Discharge Guidance and the Readiness of Discharge after Coronary Artery Bypass Surgery.. 2024. doi: 10.12201/bmr.202410.00047

  HU Linlin, ZHANG Yonghua. Study on early intervention of insomnia in depression treated by TCM syndrome differentiation. 2024. doi: 10.12201/bmr.202408.00051

  Zhu Guohui, Zhao Fan, Tang Zongkang, Wu Yanan. Research progress of fecal bacteria transplantation in the treatment of depression. 2024. doi: 10.12201/bmr.202408.00043

  yangfang, Lv Bingyu, Zhou Lingfang, Xie Jiahui, Shu Lingzhi, Feng Xin, Liu Yuxin. Empirical Study on reading therapy based on perma model of positive psychology. 2025. doi: 10.12201/bmr.202503.00039

  HEXin, matiantian, yuanyuepeng, zhuyuanheng, xuyiguo, wangweilong. Exploration of the pathogenesis of vascular depression based on the theory of heart-brain homoeopathy in the treatment of vascular depressionLU Caiju1,HE Xin1,YUAN Yuepeng2,MA Tiantian1,ZHU Yuanheng1,XU Yiguo2,WANG Weilong2. 2025. doi: 10.12201/bmr.202507.00080

  cuigongzhen, wangxuefen, liujian, xufangyan, lihuili. Analysis of influencing factors of depression in AIDS patients undergoing hemodialysis treatment based on Structural Equation Modeling (SEM). 2024. doi: 10.12201/bmr.202410.00037

  CHEN Manman, TENG Yuxin, ZENG Botao. Study on self-injurious and suicidal behavior, non-enzymatic antioxidants and thyroid hormones in adolescents with depressive disorder. 2024. doi: 10.12201/bmr.202412.00022

  shen pei cheng. Overview of TCM non-drug therapy of chronic kidney disease. 2024. doi: 10.12201/bmr.202409.00054

  DU Ben-feng, GENG Rui, MU Yue-xuan, HAO Xin, WANG Jing-wen. Childhood Family Dysfunction and Depression in the Elderly: Impact Contribution, Cumulative Effect and Influence mechanism. 2022. doi: 10.12201/bmr.202111.00022

  Clinical research progress of PD-1/PD-L1 inhibitor induction therapy in unresectable stage III non-small-cell lung cancer. 2025. doi: 10.12201/bmr.202501.00025

• ID	Submit time	Number	Download
  1	2025-07-18	10.12201/bmr.202509.00013V1	Download

• Public  Anonymous  To author only Submit Comments